Description
Hertraz 440 mg contains trastuzumab, a targeted biological medicine used in the treatment of certain HER2-positive cancers. Trastuzumab is a monoclonal antibody that specifically targets the HER2 protein found in some cancer cells.
Depending on the cancer type and treatment plan, trastuzumab may be used for HER2-positive breast cancer and certain other HER2-positive cancers. It may be administered alone or in combination with chemotherapy or other anticancer treatments under the supervision of an oncologist.
Frequently Asked Questions
1. What is Hertraz 440 mg used for?
Hertraz 440 mg contains trastuzumab and may be used to treat certain HER2-positive cancers, including specific types of breast cancer and gastric or gastroesophageal junction cancer.
2. How does Hertraz 440 mg work?
Trastuzumab targets the HER2 protein on cancer cells and interferes with HER2-related growth signals, helping inhibit the growth of HER2-positive cancer cells.
3. How is Hertraz 440 mg administered?
Hertraz is given as an intravenous infusion by a qualified healthcare professional. The dosage and treatment schedule are determined by the oncologist.
4. What are the common side effects of Hertraz 440 mg?
Possible side effects include fatigue, fever, chills, nausea, diarrhea, headache, infections, and infusion-related reactions. Your healthcare provider should be informed about severe or persistent symptoms.
5. Does Hertraz 440 mg require heart monitoring?
Yes. Trastuzumab can affect heart function, so your healthcare team may evaluate heart function before and during treatment, depending on your treatment plan and individual risk factors.
Additional information
| Active Ingredient (Generic Name): | Trastuzumab |
|---|---|
| Manufacturer: | Mylan Pharmaceuticals |
| Packaging: | multi dose vial |
| Strength: | 440mg |
| Delivery Time: | 6 To 15 days |
| Pack Size | 1 Ing, 3 Ing, 6 Ing |
Hannah Taylor –
Easy website, simple checkout, and good communication throughout the order. Overall, I was satisfied with the service.